Category - Developments

Developments

Titan Pharma, Walter Reed collaborating in antimalarial implants

Titan Pharmaceuticals (NASDAQ:TTNP) has entered into a cooperative research and development agreement with Walter Reed Army Institute of Research and Southwest Research Institute to evaluate development of ProNeura...

July 6, 2017

Developments

Scientus inks cannabis supply pact with Aphria

Closely-held Scientus Pharma, through its HydRx Farms unit, has entered into a major wholesale purchase agreement with Aphria (TSX:APH; OTCQB:APHQF). Under the accord, Aphria would supply more than 25,000 fully-grown...

July 4, 2017

Developments

FDA grants priority review to Theratechnologies’ ibalizumab

Theratechnologies (TSX:TH) has been notified by its partner, TaiMed Biologics, that the FDA has accepted for review the biologics license application for ibalizumab as a treatment for multidrug-resistant human...

June 30, 2017

Developments

Profound Medical to expand collaboration with Royal Philips’, acquire Sonalleve unit

Profound Medical (OTCQX:PRFMF; TSXV:PRN) has agreed to expand an existing collaboration with Royal Philips (NYSE:PHG; AEX:PHIA) and acquire Philips’ Sonalleve MR-HIFU business, establishing Profound as a market leader...

June 30, 2017

Developments

IntelGenx files final prospectus for debenture offering

IntelGenx Technologies (OTCQX:IGXT; TSXV:IGX) has filed a final short form prospectus in connection with its previously announced offering of a minimum of $5-million and a maximum of $10-million principal amount of 8%...

June 30, 2017

Developments

Fortune hails Titan’s ProNeura technology

Fortune.com has featured Titan Pharmaceuticals (NASDAQ:TTNP) and its ProNeura technology, calling it a “formidable new class of pharmaceutical implants.” The article said Titan’s Probuphine implant for the treatment of...

June 28, 2017

Developments

IntelGenx gets U.S. patent allowance for oral films

IntelGenx (OTCQX:IGXT; TSXV:IGX;) has received a notice of allowance from the U.S. Patent and Trademark Office for a patent application entitled, “Solid oral film dosage forms and methods for making same.” The platform...

June 27, 2017

Developments

Stryker to acquire Novadaq Technologies

Stryker (NYSE:SYK) has agreed to acquire Novadaq Technologies (NASDAQ:NVDQ; TSX:NDQ) for $11.75 a share, implying a total equity value of approximately $701-million. The transaction price represents a premium of...

June 19, 2017

Developments

Knight NDS for Probuphine in Canada accepted for review

Knight Therapeutics’ (TSX:GUD) New Drug Submission (NDS) for Probuphine, a subdermal implant of buprenorphine for the treatment of opioid drug dependence, has been accepted for review by Health Canada. Knight and...

June 13, 2017

Developments

3DS advances Hodgkin’s lymphoma test

The clinical trial component of 3D Signatures’ (OTCQB:TDSGF; TSXV:DXD; FSE:3D0) Hodgkin’s lymphoma test (Telo-HL) validation program is under way. This process is referred to as Stage 3 of the validation program...

June 8, 2017

Category - Developments

Titan Pharma, Walter Reed collaborating in antimalarial implants

Scientus inks cannabis supply pact with Aphria

FDA grants priority review to Theratechnologies’ ibalizumab

Profound Medical to expand collaboration with Royal Philips’, acquire Sonalleve unit

IntelGenx files final prospectus for debenture offering

Fortune hails Titan’s ProNeura technology

IntelGenx gets U.S. patent allowance for oral films

Stryker to acquire Novadaq Technologies

Knight NDS for Probuphine in Canada accepted for review

3DS advances Hodgkin’s lymphoma test

General

More